Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF‐κB activation and recurrent dexamethasone administration fails to suppress it in vivo

View through CrossRef
BackgroundPrevious studies have shown the effect of bacterial lipopolysaccharide (LPS) on enhanced cancer cells’ growth and metastasis. However, the effect of LPS on prostate cancer (PCa) cells metastasis has not been investigated in details. This study aimed to investigate the functional role of LPS on PCa cells metastasis and determine the effect of dexamethasone (DEX) on this event.MethodsTwo different PCa reporter cells lines (DU145‐NF‐κB‐Luc and MAT‐LyLu‐ NF‐κB‐Luc) were used to assess the direct effect of LPS on NF‐κB activation in PCa cells. Plasma collected from LPS‐stimulated human and rodent blood were used to check the indirect effect of LPS on NF‐κB activation in PCa cells. Trans‐well migration assay and two different orthotopic PCa animal models were used to investigate the effect of LPS on DU145 and MAT‐LyLu cells migration or metastasis in vitro and in vivo, respectively. In all the studies DEX was used with or without LPS stimulation.ResultsLPS and secretory factors present in plasma collected from LPS‐stimulated blood, significantly activated NF‐κB in DU145, and MAT‐LyLu cells and enhanced their migration in vitro. DEX significantly suppressed LPS‐mediated activation of cancer and blood cells and abrogated the direct and indirect pro‐migratory effect of LPS on PCa cells. Systemic administration of LPS activated NF‐κB in DU145 cells in vivo; however, failed to alter the metastatic properties of these cells. On the other hand, systemic administration of LPS to MAT‐LyLu tumor bearing animals significantly enhanced the incidence of metastasis without altering the overall growth of primary tumors. Unexpectedly, though DEX significantly suppressed MAT‐LyLu primary tumor weights, it aggravated metastasis of cancer cells in presence and absence of LPS. Moreover, consecutive DEX pre‐treatment enhanced experimental peritoneal metastasis of MAT‐LyLu cells. At the molecular level, LPS, and/or DEX induced overexpression of immunosuppressive molecules in MAT‐LyLu tumors.ConclusionsOverall, our study has shown that LPS and/or LPS induced inflammation can increase PCa metastasis and immunosuppressive dose of DEX might further enhance cancer metastasis.
Title: Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF‐κB activation and recurrent dexamethasone administration fails to suppress it in vivo
Description:
BackgroundPrevious studies have shown the effect of bacterial lipopolysaccharide (LPS) on enhanced cancer cells’ growth and metastasis.
However, the effect of LPS on prostate cancer (PCa) cells metastasis has not been investigated in details.
This study aimed to investigate the functional role of LPS on PCa cells metastasis and determine the effect of dexamethasone (DEX) on this event.
MethodsTwo different PCa reporter cells lines (DU145‐NF‐κB‐Luc and MAT‐LyLu‐ NF‐κB‐Luc) were used to assess the direct effect of LPS on NF‐κB activation in PCa cells.
Plasma collected from LPS‐stimulated human and rodent blood were used to check the indirect effect of LPS on NF‐κB activation in PCa cells.
Trans‐well migration assay and two different orthotopic PCa animal models were used to investigate the effect of LPS on DU145 and MAT‐LyLu cells migration or metastasis in vitro and in vivo, respectively.
In all the studies DEX was used with or without LPS stimulation.
ResultsLPS and secretory factors present in plasma collected from LPS‐stimulated blood, significantly activated NF‐κB in DU145, and MAT‐LyLu cells and enhanced their migration in vitro.
DEX significantly suppressed LPS‐mediated activation of cancer and blood cells and abrogated the direct and indirect pro‐migratory effect of LPS on PCa cells.
Systemic administration of LPS activated NF‐κB in DU145 cells in vivo; however, failed to alter the metastatic properties of these cells.
On the other hand, systemic administration of LPS to MAT‐LyLu tumor bearing animals significantly enhanced the incidence of metastasis without altering the overall growth of primary tumors.
Unexpectedly, though DEX significantly suppressed MAT‐LyLu primary tumor weights, it aggravated metastasis of cancer cells in presence and absence of LPS.
Moreover, consecutive DEX pre‐treatment enhanced experimental peritoneal metastasis of MAT‐LyLu cells.
At the molecular level, LPS, and/or DEX induced overexpression of immunosuppressive molecules in MAT‐LyLu tumors.
ConclusionsOverall, our study has shown that LPS and/or LPS induced inflammation can increase PCa metastasis and immunosuppressive dose of DEX might further enhance cancer metastasis.

Related Results

Expression and Vascular Effects of Cyclooxygenase-2 in Brain
Expression and Vascular Effects of Cyclooxygenase-2 in Brain
Background and Purpose —Cyclooxygenase-2 (COX-2) is an inducible isoform of cyclooxygenase. Several types of brain cells in culture can express COX-2 when treated with ...
PSIX-19 Leucine supplementation alters immune responses and blood metabolites of lambs exposed to endotoxin
PSIX-19 Leucine supplementation alters immune responses and blood metabolites of lambs exposed to endotoxin
Abstract This study evaluated effects of supplemental Leu on immune responses and blood metabolites of 29 wether lambs (43.8±10.7 kg) exposed to lipopolysaccharide (...
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract Background: Prostate cancer is the second most frequent malignancy (after lung cancer) in men worldwide. It is the third most common cancer in men in Algeri...
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract The human olfactomedin 4 gene (OLFM4) encodes an olfactomedin-related glycoprotein, which our group first cloned and characterized in myeloid cells and mapp...
Abstract 1568: The role of CCL2 CCL17 CCL22-CCR4 axis in prostate cancer metastasis
Abstract 1568: The role of CCL2 CCL17 CCL22-CCR4 axis in prostate cancer metastasis
Abstract BACKGROUND: Multiple steps and factors are involved in prostate carcinogenesis and tumor progression. The early studies have found that tumor-associated mac...
Grade Group 1 Prostate Cancer Outcome by Biopsy Grade and Risk Group
Grade Group 1 Prostate Cancer Outcome by Biopsy Grade and Risk Group
ImportanceAdvocates for removing the cancer label from grade group 1 (GG1) prostate cancer detected on biopsy primarily base their argument on the observation that when only GG1 is...

Back to Top